Login to Your Account



Inotek to merge into gene therapy-focused Rocket Pharmaceuticals

By Michael Fitzhugh
Staff Writer

Wednesday, September 13, 2017

Following the failure of Inotek Pharmaceuticals Corp.'s trabodenoson to move the needle in treating glaucoma, the company has found a new way forward: a proposed merger with New York-based gene therapy startup Rocket Pharmaceuticals Ltd.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription